BLADDER UROTHELIAL CARCINOMA
Clinical trials for BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat urinary cancers
Disease control OngoingThis early-phase trial tests the safety and best dose of a combination of two or three drugs (cabozantinib, nivolumab, and possibly ipilimumab) in people with advanced genitourinary cancers that have spread. About 152 adults with these cancers will participate. The goal is to fin…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:32 UTC
-
Immunotherapy boosts bladder cancer treatment, study hopes
Disease control OngoingThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can improve outcomes for people with stage III bladder cancer that has spread to nearby lymph nodes. About 95 adults will receive either chemoradiation alone or chemoradiation…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Bladder cancer drug combo trial halted before enrolling a single patient
Disease control TerminatedThis study aimed to test two treatments for muscle-invasive bladder cancer in patients who cannot receive the standard chemotherapy drug cisplatin. The treatments were erdafitinib (a targeted pill) alone or combined with atezolizumab (an immunotherapy). The goal was to see if the…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for bladder cancer patients who can't take chemo: radiation plus immunotherapy combo tested
Disease control OngoingThis study tests whether combining radiation therapy with two immunotherapy drugs (durvalumab with or without tremelimumab) can help control advanced bladder cancer in people who cannot or will not have chemotherapy. About 13 participants with cancer that has spread or can't be s…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Could a common heart drug boost bladder cancer treatment?
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests whether adding propranolol (a heart medication) to standard immunotherapy and chemotherapy before surgery can help treat bladder cancer that has spread to lymph nodes. About 12 adults with this specific type of bladder cancer will receive the combinat…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Immunotherapy boost may help bladder cancer patients avoid surgery
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemoradiation helps people with muscle-invasive bladder cancer live longer without their cancer returning. About 475 adults with localized disease that hasn't spread are taking part. The goal is to s…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC